Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

ITIH4 and Gpx3 are potential biomarkers for amyotrophic lateral sclerosis.

Tanaka H, Shimazawa M, Takata M, Kaneko H, Tsuruma K, Ikeda T, Warita H, Aoki M, Yamada M, Takahashi H, Hozumi I, Minatsu H, Inuzuka T, Hara H.

J Neurol. 2013 Jul;260(7):1782-97. doi: 10.1007/s00415-013-6877-3. Epub 2013 Feb 23.

PMID:
23436019
2.

Redox system expression in the motor neurons in amyotrophic lateral sclerosis (ALS): immunohistochemical studies on sporadic ALS, superoxide dismutase 1 (SOD1)-mutated familial ALS, and SOD1-mutated ALS animal models.

Kato S, Kato M, Abe Y, Matsumura T, Nishino T, Aoki M, Itoyama Y, Asayama K, Awaya A, Hirano A, Ohama E.

Acta Neuropathol. 2005 Aug;110(2):101-12. Epub 2005 Jun 28.

PMID:
15983830
3.

Loss of glial fibrillary acidic protein marginally accelerates disease progression in a SOD1(H46R) transgenic mouse model of ALS.

Yoshii Y, Otomo A, Pan L, Ohtsuka M, Hadano S.

Neurosci Res. 2011 Jul;70(3):321-9. doi: 10.1016/j.neures.2011.03.006. Epub 2011 Mar 29.

PMID:
21453731
4.

[Amyotrophic lateral sclerosis with the SOD1 mutations].

Aoki M, Warita H, Itoyama Y.

Rinsho Shinkeigaku. 2008 Nov;48(11):966-9. Review. Japanese.

PMID:
19198133
5.

Rats expressing human cytosolic copper-zinc superoxide dismutase transgenes with amyotrophic lateral sclerosis: associated mutations develop motor neuron disease.

Nagai M, Aoki M, Miyoshi I, Kato M, Pasinelli P, Kasai N, Brown RH Jr, Itoyama Y.

J Neurosci. 2001 Dec 1;21(23):9246-54.

6.

Bromocriptine methylate suppresses glial inflammation and moderates disease progression in a mouse model of amyotrophic lateral sclerosis.

Tanaka K, Kanno T, Yanagisawa Y, Yasutake K, Hadano S, Yoshii F, Ikeda JE.

Exp Neurol. 2011 Nov;232(1):41-52. doi: 10.1016/j.expneurol.2011.08.001. Epub 2011 Aug 16.

PMID:
21867702
7.

Inter-alpha-trypsin inhibitor heavy chain H4 as a diagnostic and prognostic indicator in patients with hepatitis B virus-associated hepatocellular carcinoma.

Noh CK, Kim SS, Kim DK, Lee HY, Cho HJ, Yoon SY, Lee GH, Hyun SA, Kim YJ, Kim HJ, Hwang JA, Ahn SJ, Shin SJ, Lee KM, Yoo BM, Cho SW, Cheong JY.

Clin Biochem. 2014 Sep;47(13-14):1257-61. doi: 10.1016/j.clinbiochem.2014.05.002. Epub 2014 May 14.

PMID:
24836184
8.

Different human copper-zinc superoxide dismutase mutants, SOD1G93A and SOD1H46R, exert distinct harmful effects on gross phenotype in mice.

Pan L, Yoshii Y, Otomo A, Ogawa H, Iwasaki Y, Shang HF, Hadano S.

PLoS One. 2012;7(3):e33409. doi: 10.1371/journal.pone.0033409. Epub 2012 Mar 16.

9.

Appearance of phagocytic microglia adjacent to motoneurons in spinal cord tissue from a presymptomatic transgenic rat model of amyotrophic lateral sclerosis.

Sanagi T, Yuasa S, Nakamura Y, Suzuki E, Aoki M, Warita H, Itoyama Y, Uchino S, Kohsaka S, Ohsawa K.

J Neurosci Res. 2010 Sep;88(12):2736-46. doi: 10.1002/jnr.22424.

PMID:
20648658
10.

Impaired extracellular secretion of mutant superoxide dismutase 1 associates with neurotoxicity in familial amyotrophic lateral sclerosis.

Turner BJ, Atkin JD, Farg MA, Zang DW, Rembach A, Lopes EC, Patch JD, Hill AF, Cheema SS.

J Neurosci. 2005 Jan 5;25(1):108-17.

11.

Involvement of activated microglia in increased vulnerability of motoneurons after facial nerve avulsion in presymptomatic amyotrophic lateral sclerosis model rats.

Sanagi T, Nakamura Y, Suzuki E, Uchino S, Aoki M, Warita H, Itoyama Y, Kohsaka S, Ohsawa K.

Glia. 2012 May;60(5):782-93. doi: 10.1002/glia.22308. Epub 2012 Feb 16.

PMID:
22344792
12.

Inter-alpha-trypsin inhibitor heavy chain 4: a novel biomarker for environmental exposure to particulate air pollution in patients with chronic obstructive pulmonary disease.

Lee KY, Feng PH, Ho SC, Chuang KJ, Chen TT, Su CL, Liu WT, Chuang HC.

Int J Chron Obstruct Pulmon Dis. 2015 Apr 24;10:831-41. doi: 10.2147/COPD.S81611. eCollection 2015.

13.

Immunoreactivity of the phosphorylated axonal neurofilament H subunit (pNF-H) in blood of ALS model rodents and ALS patients: evaluation of blood pNF-H as a potential ALS biomarker.

Boylan K, Yang C, Crook J, Overstreet K, Heckman M, Wang Y, Borchelt D, Shaw G.

J Neurochem. 2009 Dec;111(5):1182-91. doi: 10.1111/j.1471-4159.2009.06386.x. Epub 2009 Sep 18.

14.

Integrative gene-tissue microarray-based approach for identification of human disease biomarkers: application to amyotrophic lateral sclerosis.

Kudo LC, Parfenova L, Vi N, Lau K, Pomakian J, Valdmanis P, Rouleau GA, Vinters HV, Wiedau-Pazos M, Karsten SL.

Hum Mol Genet. 2010 Aug 15;19(16):3233-53. doi: 10.1093/hmg/ddq232. Epub 2010 Jun 8.

PMID:
20530642
15.

[Development of motor neuron restorative therapy in amyotrophic lateral sclerosis using hepatocyte growth factor].

Aoki M, Warita H, Suzuki N, Itoyama Y.

Rinsho Shinkeigaku. 2009 Nov;49(11):814-7. Review. Japanese.

PMID:
20030218
16.

Oxidant-antioxidant imbalance in the erythrocytes of sporadic amyotrophic lateral sclerosis patients correlates with the progression of disease.

Babu GN, Kumar A, Chandra R, Puri SK, Singh RL, Kalita J, Misra UK.

Neurochem Int. 2008 May;52(6):1284-9. doi: 10.1016/j.neuint.2008.01.009. Epub 2008 Jan 20.

PMID:
18308427
17.

Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS).

Howland DS, Liu J, She Y, Goad B, Maragakis NJ, Kim B, Erickson J, Kulik J, DeVito L, Psaltis G, DeGennaro LJ, Cleveland DW, Rothstein JD.

Proc Natl Acad Sci U S A. 2002 Feb 5;99(3):1604-9. Epub 2002 Jan 29.

18.

Decreased level of 5-methyltetrahydrofolate: a potential biomarker for pre-symptomatic amyotrophic lateral sclerosis.

Zhang X, Chen S, Li L, Wang Q, Le W.

J Neurol Sci. 2010 Jun 15;293(1-2):102-5. doi: 10.1016/j.jns.2010.02.024. Epub 2010 Mar 23.

PMID:
20334883
19.

Survival motor neuron deficiency enhances progression in an amyotrophic lateral sclerosis mouse model.

Turner BJ, Parkinson NJ, Davies KE, Talbot K.

Neurobiol Dis. 2009 Jun;34(3):511-7. doi: 10.1016/j.nbd.2009.03.005. Epub 2009 Mar 28.

PMID:
19332122
20.

Site-specific glycan microheterogeneity of inter-alpha-trypsin inhibitor heavy chain H4.

Chandler KB, Brnakova Z, Sanda M, Wang S, Stalnaker SH, Bridger R, Zhao P, Wells L, Edwards NJ, Goldman R.

J Proteome Res. 2014 Jul 3;13(7):3314-29. doi: 10.1021/pr500394z. Epub 2014 Jun 12.

Supplemental Content

Support Center